Business

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference

Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference Canada ...

articleBausch Health Companies Inc.May 12, 20265/company/bausch-health-companies-inc/news/bausch-health-to-participate-in-barclays-30th-annual-leveraged-finance-conference
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference

About this update from Bausch Health Companies Inc.

[{"type":"text","content":"\n\n\nBausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n\n\n\n\n\n\nCanada NewsWire\n\n\nLAVAL, QC, May 12, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that members of company management will participate in a fireside chat at the Barclays 30th Annual Leveraged Finance Conference in Austin, Texas on Tuesday, May 19, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.DetailsDate:           Tuesday, May 19, 2026Time:           10:25 a.m. U.S. ETWebcast:     http://ir.bauschhealth.com/events-and-presentationsA replay of the event will be available on the investor relations website following the event.About Bausch HealthBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.Forward-looking StatementsThis news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigat...

More updates from Bausch Health Companies Inc.